Novel Approach to Treating Androgenetic Alopecia in Females With Photobiomodulation (Low-Level Laser Therapy)
Friedman S, Schnoor P
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 33 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Randomized controlled trial (indexed by PubMed)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2017-03-23 · Dermatol Surg · vol. 43 · issue 6 · pp. 856–867
- Publisher
- Lippincott Williams & Wilkins
- Cited
- 52 citations · more than 97% of similar papers · 6.1× the field average
- Impact
- Top 10% most cited in its field
- References
- 42 works
- Access
- Paywalled
- Research areas
- Hair Growth and Disorders · Dermatologic Treatments and Research · Laser Applications in Dentistry and Medicine
- Keywords
- Scalp, Medicine, Laser therapy, Alopecia areata, Low level laser therapy, Dermatology, Randomized controlled trial, Hair follicle, Laser treatment, Laser, Surgery, Internal medicine
- MeSH
- humans, alopecia, double-blind method, adolescent, adult, middle aged, female, young adult, low-level light therapy
2 authors
From US
- Shelly A. Friedman · correspondingScottsdale Research Institute (United States)
- Patricia Schnoor
Abstract
Background
Photobiomodulation, also referred to as low-level laser therapy (LLLT), has been studied and used for (among other diseases) the promotion of hair regrowth.
Objective/materials and methods/results
A clinical study was developed to define the physiologic effects that occur when the human hair follicle and surrounding tissue structures are exposed to laser light using a novel device that is fitted with an array of laser diode sources operating at 650 nm and placed inside a sports cap to promote discretion while in use. The study demonstrates that low-level laser treatment of the scalp every other day for 17 weeks using the HANDI-DOME LASER device is a safe and effective treatment for androgenetic alopecia in healthy females between the ages of 18 to 60 with Fitzpatrick skin Types I to IV and Ludwig-Savin Baldness Scale I-2 to II-2 baldness patterns. Subjects receiving LLLT at 650 nm achieved a 51% increase in hair counts as compared with sham-treated control patients in this multicenter randomized controlled trial.
Conclusion
These results suggest that the emerging technology of low-level laser therapy may play a potentially significant role in health care providers' armamentarium for the disease androgenic alopecia.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.